Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apigenin-loaded galactose tailored PLGA nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma
Soumya Ganguly, Saikat Dewanjee, Ramkrishna Sen, et al.
Colloids and Surfaces B Biointerfaces (2021) Vol. 204, pp. 111778-111778
Closed Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

Daphnetin Ameliorates the Expansion of Chemically Induced Hepatocellular Carcinoma via Reduction of Inflammation and Oxidative Stress
Tao Li, Gang Yang, Qiwei Hao, et al.
Journal of Oleo Science (2022) Vol. 71, Iss. 4, pp. 575-585
Open Access | Times Cited: 16
Green synthesis of bovine serum albumin/oxidized gum Arabic nanocomposite as pH-responsive carrier for controlled release of piperine and the molecular docking study
Elham Saleh Jalali, Seyed Abbas Shojaosadati, Sepideh Hamedi
International Journal of Biological Macromolecules (2022) Vol. 225, pp. 51-62
Closed Access | Times Cited: 16
Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders
Pratik Chakraborty, Chiranjib Bhattacharyya, Ranabir Sahu, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105267-105267
Closed Access | Times Cited: 9
Formulation of Carnosic-Acid-Loaded Polymeric Nanoparticles: An Attempt to Endorse the Bioavailability and Anticancer Efficacy of Carnosic Acid against Triple-Negative Breast Cancer
Sharmistha Chatterjee, Pratik Chakraborty, Sayanta Dutta, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 3, pp. 1656-1670
Closed Access | Times Cited: 3
Harnessing the potential of de-sulfated heparin for targeted drug delivery: A three-component approach exemplified by conjugation with galactose and paclitaxel
Jing Yang, Xiongyan Meng, Yong Rao, et al.
Carbohydrate Polymers (2024) Vol. 333, pp. 121986-121986
Closed Access | Times Cited: 3
Novel Strategies for Tumor Treatment: Harnessing ROS-Inducing Active Ingredients from Traditional Chinese Medicine Through Multifunctional Nanoformulations
Zhengguang Zhang, M. Y. Li, Xiaolong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9659-9688
Open Access | Times Cited: 3
Food-Derived Bioactive Molecules from Mediterranean Diet: Nanotechnological Approaches and Waste Valorization as Strategies to Improve Human Wellness
Ilenia De Luca, Francesca Di Cristo, Anna Valentino, et al.
Polymers (2022) Vol. 14, Iss. 9, pp. 1726-1726
Open Access | Times Cited: 13
Synthesis, characterization, and evaluation of in vitro cytotoxicity and in vivo antitumor activity of asiatic acid-loaded poly lactic-co-glycolic acid nanoparticles: A strategy of treating breast cancer
Sayanta Dutta, Pratik Chakraborty, Susmita Basak, et al.
Life Sciences (2022) Vol. 307, pp. 120876-120876
Closed Access | Times Cited: 12
Recent Advances in Nanotechnology-Based Targeted Delivery Systems of Active Constituents in Natural Medicines for Cancer Treatment
Yu Hu, Jizheng Song, Anjie Feng, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7767-7767
Open Access | Times Cited: 7
Nano-based apigenin delivery systems for cancer applications
Izi Vieira Nunes Cunha, Angela Machado Campos, Thiago Caon
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105334-105334
Closed Access | Times Cited: 2
Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis
Anqi Wang, Yuan-Yuan Liu, Wugui Xiong, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 9, pp. 2744-2755
Closed Access | Times Cited: 2
Bovine serum albumin as a nanocarrier for efficient encapsulation of hydrophobic garcinol-A strategy for modifying the in vitro drug release kinetics
Shayeri Chatterjee Ganguly, Beduin Mahanti, Soumya Ganguly, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134651-134651
Closed Access | Times Cited: 2
Near-Infrared Responsive Synergistic Chemo-Phototherapy from Surface-Functionalized Poly(ε-caprolactone)–Poly(d,l-lactic-co-glycolic acid) Composite Nanofibers for Postsurgical Cancer Treatment
Jakia Khanom, Abdelrahman I. Rezk, Chan Hee Park, et al.
Biomacromolecules (2022) Vol. 23, Iss. 9, pp. 3582-3592
Closed Access | Times Cited: 11
Surface-functionalized luteolin-loaded nanocarriers successfully delayed lung cancer progress in rats
Ramkrishna Sen, Biswajit Mukherjee, Soumya Ganguly, et al.
Journal of Materials Science (2023) Vol. 58, Iss. 18, pp. 7731-7757
Closed Access | Times Cited: 6
Enhancing Targeted Therapy in Hepatocellular Carcinoma through a pH-Responsive Delivery System: Folic Acid-Modified Polydopamine-Paclitaxel-Loaded Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Nanoparticles
Mingfang Wu, Qi Wang, Yaya Peng, et al.
Molecular Pharmaceutics (2023) Vol. 21, Iss. 2, pp. 581-595
Closed Access | Times Cited: 6
Surface chemistry dependent toxicity of inorganic nanostructure glycoconjugates on bacterial cells and cancer cell lines
Sedanur Sancak, İdris Yazgan, Aslı Uğurlu, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104054-104054
Closed Access | Times Cited: 8
Apigenin as an emerging hepatoprotective agent: current status and future perspectives
Cheng Wang, Xiaoli Feng, Wen Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Recent Avenues in Treatment of Liver Diseases: Role of Nanotechnology
Manju Nagpal, Madhusmita Bhuyan, Malkiet Kaur, et al.
Current Drug Targets (2023) Vol. 24, Iss. 4, pp. 320-331
Closed Access | Times Cited: 3
Assessment of superiority of HSP70-targeting aptamer-functionalized drug-nanocarrier over non-targeted commercially available counterpart in HCC therapy: in vitro and in vivo investigations and molecular modeling
Samrat Chakraborty, Apala Chakraborty, Biswajit Mukherjee, et al.
Life Sciences (2023) Vol. 317, pp. 121467-121467
Closed Access | Times Cited: 3
Recent trends in the delivery of plant-derived phytochemicals against various cancers using Nanotechnological approach: A comprehensive review
Kabi Raj Chaudhary, Puja Banik, Karanvir Singh
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104859-104859
Open Access | Times Cited: 3
An update review of smart nanotherapeutics and liver cancer: opportunities and challenges
Farid Mostafaei, Somayeh Mahdinloo, Hadi Valizadeh, et al.
Nanomedicine (2023) Vol. 18, Iss. 25, pp. 1855-1873
Closed Access | Times Cited: 1
Folic acid-tripeptide-conjugated synthetic biodegradable nanoparticle-loaded with Ormeloxifene potentially inhibited breast cancer xenograft tumor
Ramkrishna Sen, Julekha Kazi, Alankar Mukherjee, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105750-105750
Closed Access
Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin
Girish Kumar, Pushpika Jain, Tarun Virmani, et al.
Therapeutic Delivery (2024) Vol. 15, Iss. 9, pp. 717-735
Closed Access
Delivery of Avocado Seed Extract Using Novel Charge-Switchable Mesoporous Silica Nanoparticles with Galactose Surface Modified to Target Sorafenib-Resistant Hepatocellular Carcinoma
Aalok Basu, Arunsajee Sae‐be, Thanaphon Namporn, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 10341-10365
Open Access
Harnessing the power of novel drug delivery systems for effective delivery of apigenin: an updated review
Vanshita Singh, Tanu Rawal, Hemant Bhati, et al.
Journal of Microencapsulation (2024), pp. 1-24
Closed Access

Scroll to top